miR-21 is one of the most frequently upregulated miRNAs in liver diseases, such as MASLD and HCC, and it plays multiple oncometabolic roles in MASLD-associated HCC via PI3K/AKT, TGF-β, and STAT3 signaling [81]. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatotic liver disease.